SatheeshChonatMD

Pediatric Hematology & Oncology • Atlanta, GA

Associate Professor, Department of Pediatrics, Emory University and Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta

Join to view full profile

Dr. Chonat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chonat's full profile

Already have an account?

Office
1405 Clifton Rd NE
Atlanta, GA 30322
Phone+1 404-785-1112

Fax+1 404-785-6288

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2012 - 2015
University of Michigan Health - Sparrow/Michigan State UniversityResidency, Pediatrics, 2009 - 2012
Cambridge University Hospitals and London School of PaediatricsSpeciality Training Registrar, General Pediatrics, Neonatology and Hematology/Oncology, 2003 - 2009
M.S. Ramaiah Medical CollegeClass of 2003

Certifications & Licensure

GA State Medical License 2015 - 2027
OH State Medical License 2012 - 2017
MI State Medical License 2009 - 2012
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Pyruvate Kinase Deficiency Natural History Study Start of enrollment: 2013 Dec 01
Completed
A Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria Start of enrollment: 2018 Feb 22
Completed
Phase 3
Pyruvate Kinase Deficiency Global Longitudinal Registry Start of enrollment: 2018 Apr 23
RECRUITING
A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD) Start of enrollment: 2018 Aug 09
Completed
Phase 3
A Study Evaluating the Efficacy and Safety of AG-348 in Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD) Start of enrollment: 2018 Jun 26
Completed
Phase 3
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period Start of enrollment: 2022 Jun 08
ACTIVE_NOT_RECRUITING
PHASE3
A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension Period Start of enrollment: 2022 Jun 06
ACTIVE_NOT_RECRUITING
PHASE3
A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD). Start of enrollment: 2022 Mar 26
ACTIVE_NOT_RECRUITING
PHASE1
Join now to see all

Publications & Presentations

PubMed

Real-world insights from a cohort of approximately 2000 individuals who were analysed using a freely available next-generation sequencing anaemia screening programme.
Jorune Balciuniene, Saliha Yilmaz, Satheesh Chonat, Rachael F Grace, Gerald A Soff
British Journal of Haematology. 2025-03-09
Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody production.
Elizabeth S York, Benjamin D Dratch, Jasmine Ito, Samantha M Horwitz, Sahand Emamian
Journal of Thrombosis and Haemostasis. 2025-02-01
Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency.
Erin L Frost, Satheesh Chonat, Kirsten M Williams, Waitman Aumann, Jason Stevenson
British Journal of Haematology. 2025-01-01

Abstracts/Posters

Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR)
Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency
Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency
Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Pyruvate Kinase (PK) Protein and Enzyme Levels in the Diagnosis and Clinical Phenotype of PK Deficiency
Satheesh Chonat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Press Mentions

Rezurock Approved for Chronic Graft-vs-Host DiseaseAugust 4th, 2021
Ultomiris Approved for Pediatric Patients with Paroxysmal Nocturnal HemoglobinuriaJune 8th, 2021
Alexion Announces FDA Approval of ULTOMIRIS® (Ravulizumab-Cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)June 7th, 2021